Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modulation of immune responses using adjuvants to facilitate therapeutic vaccination.
Schijns V, Fernández-Tejada A, Barjaktarović Ž, Bouzalas I, Brimnes J, Chernysh S, Gizurarson S, Gursel I, Jakopin Ž, Lawrenz M, Nativi C, Paul S, Pedersen GK, Rosano C, Ruiz-de-Angulo A, Slütter B, Thakur A, Christensen D, Lavelle EC. Schijns V, et al. Among authors: brimnes j. Immunol Rev. 2020 Jul;296(1):169-190. doi: 10.1111/imr.12889. Epub 2020 Jun 28. Immunol Rev. 2020. PMID: 32594569 Free PMC article. Review.
Sublingual immunotherapy in sensitized mice.
Kildsgaard J, Brimnes J, Jacobi H, Lund K. Kildsgaard J, et al. Among authors: brimnes j. Ann Allergy Asthma Immunol. 2007 Apr;98(4):366-72. doi: 10.1016/S1081-1206(10)60884-8. Ann Allergy Asthma Immunol. 2007. PMID: 17458434
Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
Hesse L, Brouwer U, Petersen AH, Gras R, Bosman L, Brimnes J, Oude Elberink JNG, van Oosterhout AJM, Nawijn MC. Hesse L, et al. Among authors: brimnes j. Clin Exp Allergy. 2018 Aug;48(8):1035-1049. doi: 10.1111/cea.13169. Epub 2018 Jun 8. Clin Exp Allergy. 2018. PMID: 29752757
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity.
Mathiesen CBK, Carlsson MC, Brand S, Möller SR, Idorn M, Thor Straten P, Pedersen AE, Dabelsteen S, Halim A, Würtzen PA, Brimnes J, Ipsen H, Petersen BL, Wandall HH. Mathiesen CBK, et al. Among authors: brimnes j. J Allergy Clin Immunol. 2018 Dec;142(6):1983-1987. doi: 10.1016/j.jaci.2018.07.030. Epub 2018 Aug 17. J Allergy Clin Immunol. 2018. PMID: 30125661 No abstract available.
29 results